Kinex Pharma makes clinical leadership appointments
This article was originally published in Scrip
Executive Summary
Buffalo, New York-based Kinex Pharmaceuticals has appointed two key executives to its clinical leadership team. Dr Douglas Kramer, a former medical officer for the US FDA, joins the company as vice-president of clinical and regulatory affairs. Meanwhile Jane Devance, who previously worked at Schering-Plough (Merck), has been appointed director of clinical operations. They will both report directly to Kinex's chief medical officer Dr Rudolf Kwan.
You may also be interested in...
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.
In Vivo’s 2024 Rising Leaders
The fifth annual listing of In Vivo’s Rising Leaders includes entrepreneurs and innovators from across the world who represent the next wave of creativity in health care.